An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

This study has been completed.
Sponsor:
Collaborators:
Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00122083
First received: July 18, 2005
Last updated: July 25, 2005
Last verified: March 2004
  Purpose

The purpose of this study is to determine the effectiveness of a simple marketing intervention in changing attitudes towards depression and its treatment among university students.


Condition Intervention
Depression
Device: Health education information

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: A Cluster Randomised Controlled Trial to Assess the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

Further study details as provided by University of Oxford:

Primary Outcome Measures:
  • The primary outcome was the proportion of participants responding positively to the question ‘Can depression be effectively treated?’

Secondary Outcome Measures:
  • Secondary outcomes included the correct identification of the symptoms of depression and the effectiveness of certain treatments.

Estimated Enrollment: 1680
Study Start Date: April 2004
Estimated Study Completion Date: June 2004
Detailed Description:

Depression is a major public health problem. It is common, affecting approximately 10 percent of the United Kingdom (UK) community at any one time. Britain’s student population is particularly at risk.

Knowledge of effective treatments for depression is burgeoning thanks to a rapid increase in the quantity and quality of relevant research. Regardless of these advances, depression is still under-reported (Freeling et al., 1985) and general practitioners often fail to diagnose it.

When depression is correctly diagnosed, most patients in primary care will receive a prescription for an antidepressant. However, some patients will not have the prescription dispensed, and most will not complete the full recommended course. Compliance with psychological treatments is also a problem.

Study Design:

  • Pilot work: The intervention consisted of mailing (to each undergraduate student’s pigeon-hole) a pack of 4 postcards which provided brief information on depression in an attractive format. One postcard summarised information on depression as an illness; one summarised information on the causes of depression; one summarised information on the treatment of depression; and one summarised information on how to seek help for depression. Prior to the trial, the drafts were revised through feedback from a focus group of 5 students, who discussed the design and content of the draft postcards. The focus group participants were recruited from the Queen’s College, as this college did not participate in the trial. The focus group contributed to the revision of the draft questionnaire.
  • The trial: The design was a cluster, randomised, controlled trial. Individual Oxford University colleges which accept undergraduate students were the units of randomisation. Twenty-eight colleges were randomised. Permanent private halls and postgraduate colleges were excluded, as was the Queen’s College (due to it being the lead investigator’s college) and Harris Manchester College (a college for mature students).

Half of the randomised colleges received no intervention; the other half received the intervention.

A questionnaire was administered before and after the intervention to half of the undergraduate students in each of the colleges. The same questionnaire was used for both time points. Questions addressed knowledge of, and attitudes towards:

  • depression as an illness;
  • symptoms of depression;
  • treatment for depression;
  • sources of help for depression.
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Undergraduate students at Oxford University

Exclusion Criteria:

  • Postgraduate students
  • Students at the excluded colleges
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00122083

Locations
United Kingdom
University of Oxford
Oxford, Oxfordshire, United Kingdom, OX1 3JX
Sponsors and Collaborators
University of Oxford
Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
Principal Investigator: John Geddes University of Oxford
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00122083     History of Changes
Other Study ID Numbers: UOxford
Study First Received: July 18, 2005
Last Updated: July 25, 2005
Health Authority: United Kingdom: National Health Service

Keywords provided by University of Oxford:
Depression
Students
Health education

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mental Disorders
Mood Disorders

ClinicalTrials.gov processed this record on October 22, 2014